Keyphrases
Primary Care
100%
Spain
45%
Catalonia
41%
Non-valvular Atrial Fibrillation
38%
Electronic Health Records
31%
Confidence Interval
29%
Vitamin K Antagonists
25%
Narcolepsy
25%
Randomized Clinical Trial
25%
SIDIAP
25%
Blood Pressure
23%
Stroke Prevention
20%
Type 2 Diabetic Patients
19%
Paracetamol
19%
Placebo
18%
Sweden
18%
Nested Case-control Study
18%
Antidepressants
18%
Comorbidity
18%
Atrial Fibrillation
17%
Molluscum Contagiosum
17%
Potassium Hydroxide
17%
Healthcare Electronics
17%
Orphan Medicinal Product
17%
Acute Liver Injury
17%
Population-based
17%
Statin Use
17%
Europe
17%
Dabigatran
17%
Denmark
15%
Hazard Ratio
15%
Moderate to Severe
14%
Clinical Trials
14%
Cardiovascular Risk
14%
Drug Therapy
14%
Taiwan
12%
Germany
12%
Pneumonia
11%
Statins
11%
Metformin
11%
Peripheral Arterial Disease
11%
ICD-10 Codes
11%
Propensity Score
10%
Agomelatine
10%
Odds Ratio
10%
Population-based Cohort Study
10%
Hospital Admission
10%
Canada
10%
Incidence Rate
10%
Rhythm Control
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
52%
Cerebrovascular Accident
36%
Cohort Study
32%
Randomized Clinical Trial
27%
Cross-Sectional Study
27%
Antivitamin K
26%
Narcolepsy
25%
Adverse Event
25%
Clinical Trial
22%
Anticoagulant Agent
21%
Disease
21%
Paracetamol
20%
Case-Control Study
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
19%
Placebo
17%
Dabigatran
17%
Antidepressant
17%
Cardiovascular Risk
17%
Comorbidity
16%
Pharmacotherapy
16%
Prevalence
11%
Diabetes Mellitus
11%
Acetylsalicylic Acid
11%
Peripheral Occlusive Artery Disease
11%
Thromboembolism
10%
Bleeding
10%
Agomelatine
10%
Influenza A (H1N1)
9%
Cholinergic Receptor Blocking Agent
9%
Bronchitis
9%
Cardiovascular Disease
9%
Non Insulin Dependent Diabetes Mellitus
9%
Brain Hemorrhage
9%
Molluscum contagiosum
8%
Potassium Hydroxide
8%
Bronchodilating Agent
8%
Analgesic Agent
8%
Statin (Protein)
8%
Pandemic Influenza
8%
Ischemic Heart Disease
8%
Live Attenuated Influenza Vaccine
8%
Apixaban
8%
SARS Coronavirus
8%
Hypocholesterolemic Agent
8%
Prematurity
8%
Antitussive Agent
8%
Base
8%
Acute Coronary Syndrome
8%
Controlled Clinical Trial
8%
Clinical Feature
8%
Medicine and Dentistry
Primary Health Care
83%
Atrial Fibrillation
35%
Randomized Clinical Trial
28%
Apoplexy
26%
Case-Control Study
25%
Blood Pressure
23%
Cross Sectional Study
22%
Electronic Health Record
20%
Placebo
20%
Paracetamol
20%
Adverse Event
17%
Antithrombotic
17%
Narcolepsy
17%
Prevalence
17%
Potassium Hydroxide
17%
Cardiovascular Risk
17%
Molluscum contagiosum
17%
Diabetes
15%
Vitamin K Antagonist
15%
Health Care Cost
13%
Clinical Trial
13%
Drug Therapy
12%
Diabetes Mellitus
11%
Patient with Type 2 Diabetes
11%
Cohort Analysis
11%
Glycon
10%
Thromboembolism
10%
ICD-10
10%
Bronchitis
9%
Parasympatholytic
9%
Rhythm
9%
Chronic Kidney Disease
9%
Cerebral Hemorrhage
8%
Statin
8%
Hazard Ratio
8%
Acetylsalicylic Acid
8%
Chronic Obstructive Pulmonary Disease
8%
Cohort Study
8%
Community-Acquired Pneumonia
8%
Apixaban
8%
ICD-9
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Bronchodilating Agent
8%
Rapid Assessment
8%
Staphylococcus Aureus
8%
Hypocholesterolemic Agent
8%
Primary Prevention
8%
Dabigatran
8%
Controlled Clinical Trial
8%
Systematic Review
8%
